| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 1 | 1 | 1 | 11 | 8 | 8 | 12 | 11 | 12 | 12 |
| Expenses | 1 | 1 | 1 | 2 | 3 | 6 | 5 | 2 | 0 | 1 | 10 | 8 | 7 | 10 | 9 | 10 | 10 |
| EBITDA | -0 | -0 | -0 | -0 | -0 | -2 | -1 | -1 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Operating Profit % | -9 % | -14 % | -14 % | -26 % | -18 % | -44 % | -42 % | -148 % | 25 % | -6 % | 4 % | 5 % | 9 % | 12 % | 14 % | 15 % | 16 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | -1 | -1 | -2 | -2 | -1 | 0 | -0 | 1 | 0 | 1 | 2 | 2 | 2 | 2 |
| Tax | -0 | -0 | 0 | -0 | -0 | -1 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net Profit | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | 0 | -0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| EPS in ₹ | -0.25 | -0.26 | -0.22 | -0.58 | -0.50 | -1.87 | -1.55 | -1.08 | 0.17 | -0.14 | 0.29 | 0.22 | 0.32 | 0.80 | 0.66 | 0.78 | 0.88 |
EIKO Lifesciences
EIKO Lifesciences
53.10
+0.05
(0.09%)
Market Cap
72.87 Cr
PE Ratio
14.34
Volume
2,405.00
Day High - Low
54.65 - 53.10
52W High-Low
65.90 - 42.00
Key Fundamentals
Market Cap
72.87 Cr
EPS
1.62
PE Ratio
14.34
PB Ratio
1.24
Book Value
42.22
EBITDA
3.50
Dividend Yield
0.00 %
Industry
Chemicals Sector
Specialty Chemicals Return on Equity
4.07
Debt to Equity
0.05
Actual
Company News
View All News
Eiko LifeSciences Limited shareholders approved two special resolutions for issuance of 33,00,000 warrants and 6,75,000 equity shares on preferential basis during extraordinary general meeting held on January 7, 2026.
SEBI imposed ₹1.00 lakh penalty on Eiko LifeSciences' promoter group entity Lenus Finvest for alleged non-compliance with SAST regulations during November 2019 to June 2021. Company confirms no financial impact.
Eiko Life Sciences EGM for ₹21.86 cr fundraise
Dec 12, 2025
Dec 12, 2025Eiko Life Sciences to hold EGM on January 7, 2026, seeking approval for preferential issue of 33 lakh warrants at ₹55 each and 6.75 lakh equity shares, raising ₹21.86 crores for strategic acquisition of SSM Formulations.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,464.90 | #1 1,49,084.93 | 64.43 | 13,387.50 | 6.91 | #1 2,096 | 11.97 | 48.15 | |
2,689.10 | 79,711.60 | 44.64 | 14,825.80 | 12.13 | 1,251 | 59.61 | 35.69 | |
3,425.70 | 37,631.31 | 57.10 | 4,853.20 | 10.61 | 546 | -19.05 | 54.90 | |
6,526.00 | 33,427.82 | 59.97 | 2,393.10 | 12.83 | 289 | 121.77 | 60.04 | |
489.70 | 24,705.12 | 33.95 | 4,664.30 | 10.33 | 555 | 36.07 | 65.76 | |
1,604.00 | 21,877.44 | 41.96 | 8,365.80 | 7.84 | 697 | 1.73 | 45.78 | |
6,581.00 | 19,375.62 | #1 31.94 | 5,692.40 | #1 18.99 | 499 | 39.62 | 61.11 | |
450.65 | 16,340.29 | 43.57 | 7,285.40 | 14.16 | 331 | #1 189.13 | 63.41 | |
1,506.60 | 15,618.26 | 34.70 | 2,292.50 | 18.24 | 405 | 7.58 | 44.66 | |
3,573.60 | 15,468.56 | 40.64 | #1 15,339.40 | 10.81 | 479 | 2.99 | 40.57 |
Growth Rate
Revenue Growth
269.23 %
Net Income Growth
-163.89 %
Cash Flow Change
984.85 %
ROE
-101.25 %
ROCE
-103.12 %
EBITDA Margin (Avg.)
-120.90 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2025 |
| Total Assets | 11 | 9 | 12 | 66 |
| Fixed Assets | 2 | 2 | 2 | 23 |
| Current Assets | 6 | 4 | 5 | 33 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 3 | 2 | 0 | 7 |
| Other Assets | 6 | 6 | 10 | 36 |
| Total Liabilities | 11 | 9 | 12 | 66 |
| Current Liabilities | 5 | 4 | 9 | 6 |
| Non Current Liabilities | 1 | 0 | 2 | 3 |
| Total Equity | 6 | 5 | 1 | 57 |
| Reserve & Surplus | 2 | 1 | -1 | 43 |
| Share Capital | 4 | 4 | 4 | 14 |
Cash Flow
| Cash Flow | 2017 | 2018 | 2019 | 2020 | 2025 |
| Net Cash Flow | 0 | 0 | -1 | -0 | -2 |
| Investing Activities | 0 | 0 | -0 | -1 | -11 |
| Operating Activities | 0 | 0 | 0 | -0 | 3 |
| Financing Activities | 0 | 0 | -1 | 1 | 7 |
Share Holding
| % Holding | Mar 2021 | May 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Jan 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Mar 2025 | Jun 2025 | Aug 2025 | Sept 2025 | Dec 2025 |
| Promoter | 21.37 % | 9.82 % | 9.82 % | 9.82 % | 9.82 % | 10.59 % | 13.48 % | 14.68 % | 23.03 % | 23.73 % | 23.73 % | 24.23 % | 24.23 % | 24.23 % | 24.23 % | 24.40 % | 24.40 % | 31.27 % | 31.27 % | 31.27 % | 36.23 % | 36.74 % | 37.11 % | 37.17 % | 37.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 59.91 % | 63.89 % | 63.93 % | 64.04 % | 63.97 % | 62.09 % | 53.44 % | 52.95 % | 55.17 % | 53.87 % | 53.34 % | 54.94 % | 54.06 % | 53.96 % | 51.62 % | 48.92 % | 49.05 % | 45.17 % | 44.97 % | 44.82 % | 44.38 % | 44.35 % | 43.49 % | 43.37 % | 43.38 % |
| Others | 18.72 % | 26.29 % | 26.26 % | 26.14 % | 26.21 % | 27.32 % | 33.08 % | 32.36 % | 21.80 % | 22.40 % | 22.93 % | 20.83 % | 21.71 % | 21.80 % | 24.15 % | 26.68 % | 26.55 % | 23.56 % | 23.76 % | 23.91 % | 19.39 % | 18.91 % | 19.40 % | 19.47 % | 19.46 % |
| No of Share Holders | 298 | 381 | 380 | 389 | 420 | 537 | 585 | 809 | 1,142 | 1,874 | 2,155 | 2,722 | 2,637 | 2,728 | 3,000 | 2,938 | 3,140 | 3,199 | 3,456 | 3,565 | 3,336 | 3,322 | 3,203 | 3,150 | 3,092 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Mar 2021 |  Change Of Name | NA | 01 Mar 2021 | 41.70 | 41.70 |
| 07 Jul 2023 |  Rights | 2:3 | 07 Jul 2023 | 61.28 | 67.51 |
| 28 Sept 2024 |  Annual General Meeting | NA | 28 Sept 2024 | 57.61 | 58.00 |
| 19 Oct 2024 |  Quarterly Result Announcement | NA | 19 Oct 2024 | 67.35 | 63.26 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 57.03 | 48.47 |
| 14 May 2025 | Quarterly Result Announcement | NA | 14 May 2025 | 49.08 | 49.03 |
| 29 Jul 2025 | Quarterly Result Announcement | NA | 29 Jul 2025 | 54.22 | 51.79 |
| 05 Sept 2025 | Annual General Meeting | NA | 05 Sept 2025 | 51.79 | 51.34 |
| 31 Oct 2025 | Quarterly Result Announcement | NA | 31 Oct 2025 | 51.75 | 52.68 |
| 07 Jan 2026 |  Extraordinary General Meeting | NA | 07 Jan 2026 | 53.18 | 53.46 |
| 29 Jan 2026 | Quarterly Result Announcement | NA | 29 Jan 2026 | 53.95 | 50.59 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 30, 2026
Jan 30, 2026Board Meeting Outcome for Outcome Of Board Meeting Dated 29Th January 2026Jan 29, 2026
Jan 29, 2026Board Meeting Intimation for Meeting Scheduled For Quarterly Results For The Quarter Ended 31St December 2025Jan 16, 2026
Jan 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Jan 09, 2026Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 09, 2026
Jan 09, 2026Shareholder Meeting / Postal Ballot-Outcome of EGMJan 07, 2026
Jan 07, 2026Disclosure Under Regulation 30 For Adjudication Order Passed By SEBI On Promoter Group EntityJan 05, 2026
Jan 05, 2026Closure of Trading WindowDec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 13, 2025
Dec 13, 202501St Extra-Ordinary General Meeting To Be Held On Wednesday 07Th January 2026Dec 12, 2025
Dec 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 12, 2025
Dec 12, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesDec 11, 2025
Dec 11, 2025Announcement under Regulation 30 (LODR)-AcquisitionDec 11, 2025
Dec 11, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th December 2025Dec 11, 2025
Dec 11, 2025Board Meeting Intimation for Considering Raising Of FundsDec 08, 2025
Dec 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 01, 2025
Nov 01, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 31St October 2025Oct 31, 2025
Oct 31, 2025Board Meeting Intimation for Meeting Scheduled On Friday 31St October 2025Oct 17, 2025
Oct 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 11, 2025
Oct 11, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 06, 2025
Sep 06, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 05, 2025
Sep 05, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 04, 2025
Sep 04, 2025Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 (The Listing Regulations)Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Reg. 34 (1) Annual Report.Jul 30, 2025
Jul 30, 2025Reg 34 (1) - Annual Report For The FY 2024-25.Jul 29, 2025
Jul 29, 2025Notice Of The 48Th AGM Of The Company For The Financial Year 2024-25Jul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 29, 2025
Jul 29, 2025Board Meeting Outcome for Outcome Of The Board MeetingJul 29, 2025
Jul 29, 2025Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesJul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 29, 2025
Jul 29, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 24, 2025
Jul 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Jul 11, 2025Clarification On Price MovementJul 04, 2025
Jul 04, 2025Clarification sought from Eiko Lifesciences LtdJul 04, 2025
Jul 04, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 26, 2025
Jun 26, 2025Closure of Trading WindowJun 25, 2025
Jun 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Revised Financial Results For Quarter And Year Ended 31St March 2025May 14, 2025
May 14, 2025Revise Outcome Of Board Meeting Dated 14.05.2025May 14, 2025
May 14, 2025Appointment Of Secretarial AuditorMay 14, 2025
May 14, 2025Appointment Of Internal AuditorMay 14, 2025
May 14, 2025Results For Quarter And Year Ended 31St March 2025May 14, 2025
May 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated 14.05.2025May 14, 2025
May 14, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 14, 2025
May 14, 2025Board Meeting Intimation for Approval Of Financial Results And Other AgendasMay 07, 2025
May 07, 2025Technical Indicators
RSI(14)
Neutral 55.00
ATR(14)
Less Volatile 2.16
STOCH(9,6)
Neutral 67.95
STOCH RSI(14)
Overbought 96.48
MACD(12,26)
Bullish 0.21
ADX(14)
Weak Trend 10.97
UO(9)
Bearish 40.32
ROC(12)
Uptrend And Accelerating 3.66
WillR(14)
Neutral -23.89
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
